FDA panel backs Vanda's circadian rhythm drug - Reuters

[INCIID News Feed]

Drug Discovery & Development
<img alt="" height="1" width="1" />
FDA panel backs Vanda&#39;s circadian rhythm drug
Reuters
(Reuters) - An advisory panel to the Food and Drug Administration said on Thursday that an experimental drug designed to help regulate the internal body clocks of blind patients appears safe and effective. The drug, tasimelteon, is designed to treat ...
Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to ...Wall Street Journal
Regulatory decision looms for Vanda PharmaceuticalsWashington Business Journal
Vanda Pharmaceuticals Inc. (VNDA): Vanda scores clean sweep at Ad ComSeeking Alpha
NASDAQ
all 15 news articles &raquo;


More...